INTRODUCTION
Rational drug design is a focused approach to aid traditional drug discovery to reduce experimental cost and time. This basically involves identification or creation of candidate drug like molecule using the information about the structure of a drug receptor or one of its natural ligands. It includes four essential steps as shown in Fig. 1 . Virtual screening is basically an approach to search the whole known chemical space with the aid of computational techniques. It strives to find novel molecular scaffold which can act as drug against a particular given target protein. It focuses on defining the criteria for filtering the large chemical databases and applying them to find small molecules with desired properties which can bind to a given drug target and act as a drug. Several approaches used for virtual screening includes Hansch analysis, Free-Wilson analysis, Hansch FreeWilson mixed approach [1] , [2] , active site interactions [3] or de novo models [4] , [5] , 3D-pharmacophore based design [6] , comparative molecular field analysis CoMFA [7] , [8] and molecular docking [9] , [10] . Quantitative structure activity relationship, QSAR [11] , [2] is an approach to rational drug design that is based on the concept that the structure and biological properties of a molecule are interrelated. It includes Hansch and Free-Wilson analyses. Hansch analysis correlates physicochemical properties to biological activity of a molecule. FreeWilson is a numerical method which directly relates structural features with biological properties. Both approaches are closely interrelated, theoretically as well as in their practical applications. Thus, both the approaches are often used combinatorially where, biological activity due to certain structural modifications are calculated using Free-Wilson type parameters and physicochemical parameters are used to describe the effect of some other substituent on the biological activity [12] . Basically, in QSAR approach, a molecular structure is represented using the computable molecular descriptors (broadly hydrophobic, electronic and steric) to compute the biological activity with the equations relating them. These equations are used to calculate the biological activity of different synthesized and predicted molecules against a given target to ensure their effectiveness as a drug.
Pharmacophore can be defined as -a set of structural features in a molecule that is recognized at a receptor site and is responsible for that molecule's biological activity‖ [13] . Pharmacophore modeling involves the following steps that are iteratively performed until a desired result is obtained: Identification of structural and chemical features common in biologically active molecules, measurement of three dimensional orientation of the common features, defining a pharmacophore, validation of the pharmacophore to be harbored by active compounds and not by any inactive compound and refining of the pharmacophore model by applying the same to compounds with known functionality. This approach is more useful when the structural information of the target protein in unknown. In [14] and [15] pharmacophore modeling has been used as a tool to screen large libraries to find inhibitors of given target.
The principal concept underlying Comparative Molecular Field Analysis (CoMFA), is that the difference in biological activity of a molecule is due to the changes in shapes and strength of its non-covalent interaction (steric and electrostatic) to its surroundings. For CoMFA analysis, a set of molecules is required. Each conformation of these molecules is considered to be the active structure, and is placed on the cubic grid to calculate its biological activity by finding its surrounding molecular field using appropriate probe. An article enunciating a study on epothilones using CoMFA is discussed in [8] . Docking is also an efficient approach to rational drug design which tries to -predict the structure and binding free energy of a ligand receptor complex given only the structure of the free ligand and receptor‖ [1] . An automated docking program, DOCK, was proposed in [3] . A docking problem can be broken to basic three steps as shown in Fig. 2 : (i) defining the potential drug target and identification of its active site to which the drug molecule must bind, (ii) modeling a drug like small molecule and study of its interaction with the receptor protein, and (iii) performing the conformational and orientation search to find low energy states of the system that can correlate to the original binding model.
Structural study of the target and its active site

Studying the interaction between probable drug candidates and the target
Studying the orientation and conformation of the target inhibitor complex Predict Binding Affinity
Fig. 2 Steps involved in docking studies
Active site of a protein is a localized combination of amino acid groups within its tertiary (3D) or quaternary structure that are capable of interacting with a chemically specific substrate which provides the protein with its biological activity. Virtual screening involving active site interactions can be categorized into two groups. The first approach strives to find molecules interacting optimally to the active site by searching different databases of known small drug like molecules and second, involves building de novo models of ligands complementary to a given active site. De novo design can be done in two ways: Outside-in and Inside-out approaches. In Outsidein approach the binding site is analyzed to determine where specific functional groups might bind properly so that these functional groups can be connected to build a real molecule. On the other hand, Inside-out approach involves growing a ligand molecule within the given active site using an appropriate search algorithm where each proposed ligand is evaluated using an energy function [4] , [16] , [17] .
Several computational concepts have been facilitated for the above mentioned approaches of virtual screening. In the present article we would emphasize on the use of support vector machines (SVM) for these virtual screening approaches.
SUPPORT VECTOR MACHINES
Support vector machines was invented by Vapnik et.al.,in 1979 [18] , [19] , [20] . It is a machine learning technique to facilitate classification. Two basic concepts essential for support vector machines are a maximal margin classifier and a kernel function. The former is responsible for the construction of a separating hyperplane so that the distance between the different classes is maximized. The latter is used to map the data in a new space where they are separable.
Firstly the SVM is trained using a learning data set. This data set necessarily contains data divided in two classes. When these training data are linearly separable the algorithm learns to construct the unique hyperplane having the maximal margin (δ) separating the training objects into two classes as show in Fig. 3a . However, the data can also be linearly inseparable. In such a scenario the algorithm projects the input data vectors to a higher dimensional feature space using kernel functions [20] , [21] . Thereafter these projections of the data are classified by constructing a hyperplane as shown in Fig. 3b . 
APPLICATION OF SVM IN VIRTUAL SCREENING
Virtual screening basically involves examination of many molecules to find active molecules against a given target. This is generally done with the knowledge of the known inhibitors of the given target. If the molecular properties of a set of molecule which is active against a target of interest are known then the vast chemical space can be searched to fetch such molecules which possess the same properties. If a classifier is trained with the molecular properties of the known inhibitors of a given target then the classifier can predict or classify other molecules from the chemical databases to active or inactive against the same target. Therefore the problem of virtual screening can be well framed as a classification problem. The ability of SVM to successfully classify linearly and non linearly separable data has made its application popular in drug design, virtual screening and combinatorial chemistry [22] , [23] , [24] , [25] , [26] , [27] .
In [28] the authors have reported results of such an analysis using SVM. Here molecules in five data sets were ranked according to their activity against given targets. This approach uses Gaussian kernel and those molecular descriptors for which the values of active and inactive molecules lie in different and distinct ranges. SVM has also been applied for activity prediction of small molecules other than their classification and ranking.
Yao et. al., had proposed an SVM based technique to predict the activity of cyclooxygenase 2 (COX-2) inhibitors [29] . The kernel function used for the study was radial basis function. The structure of the molecules was described using several molecular descriptors. These include one constitutional descriptor, one geometrical descriptor, one topological index, one electrostatic descriptor, and two quantum chemical descriptors. Another approach in [30] elucidates the application of SVM for drug-likeness and agrochemicallikeness prediction to aid virtual screening. It also successfully predicts the activity of several Carbonic Anhydrase II (CA II) enzyme inhibitors. The drug and agrolikeness descriptors used for the study are as follows: molecular weight, fractional absorption, log of 1-octanol/water partition coefficient at pH 7.4, log of 1-octanol/water partition coefficient (neutral form), log of water solubility (g/mL) at pH 7.4, number of hydrogen bond donors, number of hydrogen bond acceptors, number of rotatable bonds, molecular radius of gyration, atomic polarizability, dipole moment, and set of Jurs descriptors. This study demonstrated that SVM with radial basis function kernel outperforms SVM with linear kernel, multilayer perceptron, modular feed forward network and generalized feed forward network. Though, the usage of drug and agro-likeness descriptors help in predicting drug likeness and agrochemical-likeness but the authors have stated that usage of 2D and 3D descriptors will improve prediction rate. SVM models are also used for feature selection. In this case the algorithm selects the features most essential for the prediction of activity/ druggability/ toxicity/ any other property of a set of molecules. Byvatov and Schneider [31] discuss a work that uses SVM for selecting relevant No. 1, 2012, 43 -55 http://www.ijcb.in molecular descriptors from a trained classifier which could be important for better understanding of ligandreceptor interactions. In Muller.et.al., [32] another SVM based technique for drug-likeness prediction is presented. In these types of studies where feature selection and prediction are done together, the classifier is trained first using all the features available and then a feature selection algorithm is employed to discard the least important features. But the main drawback of this approach is that the classifier assumes a statistical distribution the data which may/ may not be a good approximation. Also the feature selection becomes dependent on the classification model. Therefore, these issues must always be handled while amalgamating feature selection with a prediction/ classification model. In [33] an in silico chemogenomics approach for virtual screening of G-protein coupled receptors has been discussed. This is a SVM based approach that uses a flexible framework to incorporate various information sources on the biological space of targets and on the chemical space of small molecules. The article also investigates the usage of 2D and 3D descriptors for small molecules to gauge the prediction accuracies. It shows that the inclusion of the information about the known hierarchical classification of the target family and the interacting amino acids in the binding pockets of the target under consideration significantly improves the prediction accuracy of the proposed model.
Recently a few works delineates a shift from the usual paradigm of virtual screening. These approaches use the pair potentials of active and inactive molecules instead of only their molecular descriptors to train the SVM. Li et. al., [34] use the same approach to identify EGFR kinase inhibitors. The positive data of the training set containes the pair potentials obtained from three-dimensional structures of protein-ligand complexes present in PDB. The negative data set constituted of the computed pair potentials of protein-ligand complexes obtained by docking a set of randomly chosen 10,000 molecules to EGFR. To further fine tune their results Li et. al., [34] compared the binding profile of the predicted active molecules to the binding profile of the known EGFR inhibitor, erlotinib. Here, the binding profile is referred to as the off-targets of a molecule occurring in multiple signalling pathways. This profile contains the binding affinity of a molecule to different targets spanning over several signaling pathways. Using this approach, Li et. al., were able to identify three new inhibitors of EGFR. A similar and more improved approach was proposed in [35] . The authors defined new pair potentials based on 2018 protein-ligand complexes. The negative data set in this case was more intelligently designed. It contained the computed pair potentials of the protein-ligand complexes where, the ligands were inactive molecules or decoys obtained from Directory of Useful Decoys (DUD). The rationale behind designing such a negative data set was to ensure that the SVM can efficiently distinguish between molecules that acquire the binding modes of active molecule and not the decoys. These are new approaches to virtual screening using SVM which produces promising results but, these approaches are target as well as inhibitor type specific. Therefore, virtual screening for different targets requires selection of new set of pair potentials and construction of binding profiles. Moreover, amongst these predicted molecules only very few are found to be really active against the given target when tested experimentally. Though SVM has lower prediction error in comparison to other classifiers but still it needs more endeavor to make more relevant biological predictions.
There have also been endeavors in developing new kernel functions which could be more helpful for biological predictions. Mostly SVM applications, which are used for virtual screening uses the radial basis function. In [36] a novel graph alignment kernel function is proposed, which is used for virtual screening. This method uses graphs to represent molecules. Then it applies wavelet analysis on these graphs to capture the local topologies of these molecules. The features generated in this way have been further used by the novel graph alignment kernel function to build SVM models for virtual screening. A similar approach is also discussed in [37] which is an extension or improvement of the former work. Here the kernel function is a bit improved and is termed as graph assignment kernel.
CONCLUSION
The applications discussed in this paper enunciate the effectiveness of the machine learning approaches in virtual screening. It has some definitive advantages over random selection. Therefore, it is evident that virtual screening can make important contributions to the drug discovery process. The application of machine learning is particularly beneficial when the objective is to reduce a large data set to a smaller chemical library. But, it must is noticed that the efficiency of these methods completely depends on the quality of the data set being used. Feature selection is also important for predictive model building. When feature selection and training of the model occurs simultaneously it should be taken care that the statistical distribution of the data has been chosen appropriately.
Most studies report that the SVM performs better than other machine learning approaches. But, still performance of these algorithms needs to be improved. The prediction quality of SVM can often be improved by adjusting its parameters to the particular problem. Specifically the kernel function selection for a particular
